EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study

Marta De Antonio-Cuscó, Luisa Sorlí, Rosana Muñoz-Bermúdez, Carlos López-Mula, Francisco José Parrilla, Maria Pilar Gracia-Arnillas, Núria Prim, Núria Campillo Ambrós, Juan P Horcajada, Joan Ramon Masclans-Enviz, Santiago Grau, Sònia Luque

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkae444 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Marta De Antonio-Cuscó und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Hospital del Mar, Barcelona, Spain. Hauptthemen laut MEDLINE: Linezolid, Anti-Bacterial Agents, Gram-Positive Bacterial Infections, Pleural Cavity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To describe the pharmacokinetics (PK) of linezolid in plasma and pleural fluid (PF) in critically ill patients with proven or suspected Gram-positive bacterial infections. Patients and methods Observational PK study in 14 critically ill patients treated with linezolid at standard doses. Blood and PF samples were collected and analysed by HPLC. The ratio between PF and plasma concentrations was calculated. The PK/pharmacodynamic (PD) target of linezolid in plasma was defined as 100% of the duration of the dosing interval in which concentrations were above the MIC (%100 T > MIC).

Results

The median (5th and 95th percentiles) linezolid concentration values for plasma pre-dose at steady state (Cmin,ss) and at the end of the 1-h infusion at steady state (Cmax,ss) were 1.1 (0.02–28.3) and 13.8 mg/L (2.9–38.1), respectively, and the PF pre-dose concentration (PF0 h) and PF concentration at the end of the 1-h intravenous infusion (PF1 h) were 2.8 (0.1–31.6) and 4.2 mg/L (0.1–45.2), respectively. At both times (pre-dose and post-infusion), a strong positive correlation was observed between PF and plasma linezolid concentrations (Spearman’s rho coefficients = 0.8 and 0.9, with P < 0.001 for both). The defined PK/PD target in plasma was achieved in 8 (57.1%), 4 (28.6%) and 3 (21.4%) patients assuming an MIC of 1, 2 and 4 mg/L, respectively.

Conclusions

Linezolid seems to penetrate well into the PF, with concentrations exceeding those in plasma. However, high inter-individual variability, both in plasma and PF concentrations, was observed. A high proportion of patients did not achieve the PK/PD target in plasma, especially in the presence of high MIC strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidAnti-Bacterial AgentsGram-Positive Bacterial InfectionsPleural CavityHumansCritical IllnessMaleFemaleMiddle AgedAgedRetrospective StudiesAged, 80 and overPlasmaMicrobial Sensitivity TestsAdultChromatography, High Pressure Liquid

Substanzen

LinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Pharmacy Department, Hospital del Mar, Barcelona, Spain.
  • Infectious Diseases Department, Hospital del Mar, Barcelona, Spain.
  • CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
  • Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d' Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Critical Care Department, Hospital del Mar, Hospital del Mar, Spain.

Zitieren

APA

De Antonio-Cuscó, M., Sorlí, L., Muñoz-Bermúdez, R., López-Mula, C., Parrilla, F. J., Gracia-Arnillas, M. P., Prim, N., Campillo Ambrós, N., Horcajada, J. P., Masclans-Enviz, J. R., Grau, S., & Luque, S. (2025). Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae444

Vancouver

De Antonio-Cuscó M, Sorlí L, Muñoz-Bermúdez R, López-Mula C, Parrilla FJ, Gracia-Arnillas MP, et al. Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae444

BibTeX
@article{DeAntonioCusc2025,
  author = {De Antonio-Cuscó, Marta and Sorlí, Luisa and Muñoz-Bermúdez, Rosana and López-Mula, Carlos and Parrilla, Francisco José and Gracia-Arnillas, Maria Pilar and Prim, Núria and Campillo Ambrós, Núria and Horcajada, Juan P and Masclans-Enviz, Joan Ramon and Grau, Santiago and Luque, Sònia},
  title = {Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkae444}
}
Kostenlos starten →